CD40LG (biosimilar) Antibody from BIORBYT LTD.
Search, find, compare suppliers for anti-CD40LG (biosimilar) antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | CD40LG (biosimilar) |
| Clone | IDEC-131 (Toralizumab) |
| Host Species | Recombinant |
| Reactive Species | human |
| Isotype | IgG kappa |
| Format | unconjugated |
| Size | 0.2 mg |
| Concentration | batch dependent |
| Applications | Blocking, IF |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | CD40LG Biosimilar Antibody |
| Immunogen | The original monoclonal antibody was generated by immunization with a soluble fusion protein of human gp39 (gp39-CD8). |
| Other Names | CD40L, gp39, TRAP, Tumor necrosis factor ligand superfamily member 5, TNFSF5, T-cell antigen Gp39, TNF-related activation protein, TNF-related activation protein |
| Gene, Accession # | UniProt: P29965 |
| Catalog # | orb1671579 |
| Price | $888 |
| Order / More Info | CD40LG (biosimilar) Antibody from BIORBYT LTD. |
| Product Specific References | n/a |
BIORBYT LTD.
BIORBYT LTD.
7 Signet Court
Swann Road
Cambridge, CB5 8LA U.K.
P: +44 (0)1223 859 353
F: +44(0)1223 280 240
info@biorbyt.com
http://www.biorbyt.com
U.S. OFFICE
Biorbyt LLC
1100 Corporate Square Drive
Helix Center, Suite 221
St Louis, MO 63132
Email: info@biorbyt.com
Phone: +1 (415) 906-5211
Fax: +1 (415) 651-8558
Profile of BIORBYT LTD.
Return to Antibodies